THREE OF WI HARPER’S PORTFOLIO COMPANIES HAVE MADE THE 2019VENTURE50 PRELIMINARY EVALUATION LIST: EDIGENE, HISTO PATHOLOGY, CREDITX

Three of WI Harper’s portfolio companies have made the 2019Venture50 preliminary evaluation list: EdiGene, Histo Pathology, CreditX Source: WI Harper Group The 2019Venture50 preliminary evaluation list was just released.  Since its launch earlier this April, Venture50 has attracted 7000+ projects to participate in the 2019 selection. Up until now, hundreds of investment institutions and nearly

Read more »

BRAIN-COMPUTER INTERFACE COMPANY NEURACLE RAISES RMB 60 MILLION

WI Harper-backed Neuracle Technology Co., Ltd. has officially announced the completion of a RMB 60 million financing round. To date, Neuracle has completed three rounds of financing, with a total financing scale exceeding Rmb 100million. This round of investment was led by China Control Fund, China Development Fund, China Development Frontier Fund, and BV Baidu Ventures.

Read more »

2023 PORTFOLIO HIGHLIGHTS

In the past year, despite weaknesses in the broader venture landscape, WI Harper Group has experienced a particularly special and successful period. Our portfolio has demonstrated significant growth across various innovative sectors. Most notably, Alpha Ring, a provider of nuclear fusion-enabled solutions, has made remarkable strides in the clean energy sector. Our impact extended to

Read more »

2023 Portfolio Highlights

In the past year, despite weaknesses in the broader venture landscape, WI Harper Group has experienced a particularly special and successful period. Our portfolio has demonstrated significant growth across various innovative sectors. Most notably, Alpha Ring, a provider of nuclear fusion-enabled solutions, has made remarkable strides in the clean energy sector. Our impact extended to

Read more »

DISCOVER

Resvent Medical is a Shenzhen, China-based medical device and solution company focused on medical respiration & ventilation field, with its core management team having spun out of Mindray’s hospitals respiratory division, with over a decade of experience in homecare devices, clinical respiratory healthcare, intelligent information system, related consumable & accessories and value added services, and capable of building a globally competitive respiratory player – i.e. the RESMED of China.